ProCE Banner Activity

Advances in Chronic Lymphocytic Leukemia Care: A Master Class for the Community Multidisciplinary Team

Slideset Download

Download these slides from a live webinar to gain more insight into how to effectively incorporate new and emerging agents and treatment combinations into the care of patients with CLL

Released: January 19, 2023

Expiration: January 18, 2024

No longer available for credit.

Share

Faculty

Jennifer R. Brown

Jennifer R. Brown, MD, PhD

Assistant Professor of Medicine
Department of Hematologic Malignancies
Dana-Farber Cancer Institute
Harvard Medical School
Attending Physician, Lymphoma Program
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Jeff DONOTUSESharman

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

AbbVie Inc.

AstraZeneca Pharmaceuticals

Lilly

Faculty Disclosure

Primary Author

Jennifer R. Brown, MD, PhD

Assistant Professor of Medicine
Department of Hematologic Malignancies
Dana-Farber Cancer Institute
Harvard Medical School
Attending Physician, Lymphoma Program
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Jennifer R. Brown, MD, PhD: consultant/advisor/speaker: AbbVie, Acerta, AstraZeneca, BeiGene, Bristol-Myers Squibb, Catapult, Celgene, Genentech/Roche, Hutchmed, iOnctura, Janssen, Juno, Lilly, MEI, Pharmacyclics; researcher: BeiGene, Gilead Sciences, Lilly, Loxo, MEI, SecuraBio, Sun, TG Therapeutics.

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Jeff Sharman, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, AstraZeneca, BeiGene, Bristol Myers Squibb, Genentech, Janssen, Lilly, Merck.